Dupont Capital Management’s Twist Bioscience TWST Stock Holding History

Dupont Capital Management’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,287	Closed	-$116K	–	1527
2022 Q3	$116K	Sell	3,287 -1,289	-28%	-$54.7K	0.01%	988
2022 Q2	$160K	Hold	4,576	–	–	0.01%	1040
2022 Q1	$226K	Sell	4,576 -405	-8%	-$22.4K	0.01%	1025
2021 Q4	$385K	Sell	4,981 -1,986	-29%	-$204K	0.01%	900
2021 Q3	$745K	Buy	6,967 +4,328	+164%	+$496K	0.02%	693
2021 Q2	$352K	Buy	2,639 +99	+4%	+$11.5K	0.01%	1147
2021 Q1	$315K	Buy	+2,540	New	+$386K	0.01%	1127

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Dupont Capital Management's TWST Position: Q4 2022 in Review

Dupont Capital Management sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 3,287 shares — an estimated $116K sold.

Dupont Capital Management first reported a position in TWST in Q1 2021 and held it in 7 quarters. The position peaked at $745K in Q3 2021. 198 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

Dupont Capital Management reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
Dupont Capital Management sold 3,287 Twist Bioscience shares in Q4 2022, an estimated $116K.
Dupont Capital Management first reported a position in Twist Bioscience in Q1 2021 and held it in 7 quarters.
Dupont Capital Management's Twist Bioscience position peaked at $745K in Q3 2021.
198 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.